Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension
Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension
Brief Summary:
This study evaluates the duration of intraocular pressure (IOP)-lowering effect and safety of as needed administrations of Bimatoprost sustained release (SR) in participants with open-angle glaucoma (OAG) or ocular hypertension (OHT) who are not adequately managed with topical IOP-lowering medication for reasons other than medication efficacy.
Study Type: Interventional (Clinical Trial)
Estimated Enrollment: 490 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension
Actual Study Start Date: February 28, 2019
Estimated Primary Completion Date: January 29, 2025
Estimated Study Completion Date: June 30, 2025
Arm:
- Experimental: Bimatoprost SR - Dose A
- Experimental: Bimatoprost SR - Dose B
| Category | Value |
|---|---|
| Study type(s) | Interventional |
| Estimated enrolment | 490 |
| Actual Study start date | 28 February 2019 |
| Estimated Study Completion Date | 30 June 2025 |